In May 2023, Novartis acquired the investigational autologous hematopoietic stem cell (HSC) gene therapy program for the treatment of...
read morePress release originally published May 17, 2022 on Avrobio.com. New early data show key visual motor integration, visual perception...
read moreAVROBIO has released a brochure providing detail on investigational gene therapies for lysosomal storage disorders. Earlier this year, AVROBIO’s...
read more